Bio-AMD Inc. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2017-03-31: Form 8-K; Period of report 2017-03-31; Description 8.01 Other Events; Details 8.01.
- 2017-02-06: Form 8-K; Period of report 2017-01-31; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
- 2016-12-09: Form 8-K; Period of report 2016-12-06; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
- 2016-06-20: Form 8-K; Period of report 2016-06-14; Description 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2017-03-31 | 8-K | 2017-03-31 | 8.01 Other Events | 8.01 Bio-AMD Inc. (“the Company”, “we”), is currently unable to file its annual report on Form 10-K for the year ended December 31, 2016, because of a lack of funds. | bioamd8k033017.htm |
| 2017-02-06 | 8-K | 2017-01-31 | 1.01 Entry into a Material Definitive Agreement | 1.01 On January 31, 2017, Bio-AMD, Inc. (the “ Company ”) entered into an amendment (the “ Amendment”) to a Subscription and Shareholders’ Agreement, dated June 20, 2016, as amended on September 29, 2016 and December 6, 2016 (the “MIDS Agreement”), relating to the Company’s Joint Venture vehicle, MIDS Medical Limited (“ MML” ). | bioamd8k020617.htm |
| 2016-12-09 | 8-K | 2016-12-06 | 1.01 Entry into a Material Definitive Agreement | 1.01 On December 6, 2016, Bio-AMD, Inc. (the “Company”) entered into an amendment (the “Amendment”) to a Subscription and Shareholders’ Agreement, dated June 20, 2016, as amended on September 29, 2016 (the “MIDS Agreement”), relating to the Company’s Joint Venture vehicle, MIDS Medical Limited (“MML” ). | bioamd8k120916.htm |
| 2016-06-20 | 8-K | 2016-06-14 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 On June 20, 2016 the Company and its UKH and MML subsidiaries entered into a joint venture by way of a Subscription and Shareholders’ Agreement (“Agreement”) with a third party medical detection device developer (“Partner”) a Nevada Corporation, under which the Partner will own a 40% interest in MML to be awarded on July 1, 2016, in exchange for its participation and funding to support MML during a Phase 1 development, and prospectively to fund a Phase 2 development of our MIDS universal immunoassay detection technology within the MML vehicle. 5.02 On June 14, 2016, Mr Robert Galvin was removed as Principal Financial Officer, Treasurer and director of the Company for cause, based on his not explaining certain expenses charged to the Company’s subsidiary Bio-Alternative Medical Devices Limited (“Bio”) over a two year period. | bioamd8k062016.htm |
| 2016-04-22 | 8-K | 2016-04-20 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 – Changes in Registrant’s Certifying Accountant. | bio-amd8k042216.htm |
| 2016-04-14 | 8-K | 2016-04-12 | 8.01 Other Events | 8.01 On December 17, 2014, Bio Alternative Medical Devices Ltd., (“Bio-AMD Ltd.”) a majority owned subsidiary of Bio-AMD Inc., entered into a Master Agreement (the “Agreement”) with Sysmex Corporation (“Sysmex”) to jointly conduct a feasibility study (the “Study”) for the potential development of a medical point-of-care reader device with disposable test strips for PT-INR assays and new future assays in the field of hemostasis (the “Product”) based on the Bio-AMD Ltd. COAG technology. | bioamd8k041416.htm |
| 2014-12-19 | 8-K | 2014-12-17 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into Material Definitive Agreement. | bioamd8k121914.htm |
| 2012-09-10 | 8-K | 2012-09-10 | 8.01 Other Events | 8.01 Attached to this Form 8-K is a press release made by Bio-AMD, Inc. dated September 10, 2012. | bioamd8k091012.htm |
| 2011-12-07 | 8-K | 2011-12-02 | 8.01 Other Events | 8.01 On 8 February 2011, Bio-AMD, Inc. ("Bio-AMD") commenced proceedings against Mayer Brown International LLP in the High Court of Justice, Chancery Division, London, UK under action number HC11C00257. | bioamd8k120711.htm |
| 2011-05-18 | 8-K | 2011-05-18 | 8.01 Other Events | 8.01 Attached hereto as Exhibit 99.1 is a press release issued on May 18, 2011 by Bio-AMD, Inc., f/k/a Flex Fuels Energy, Inc. (the “Company”), announcing that FINRA has approved the change of the Company’s name to Bio-AMD, Inc. and its trading symbol to “BIAD” effective at the opening of business on May 18, 2011. | bioamd8k051811.htm |
| 2011-04-20 | 8-K | 2011-04-15 | 1.01 Entry into a Material Definitive Agreement; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. | flexfuels8k04152011.htm |
| 2011-02-09 | 8-K | 2011-02-08 | 8.01 Other Events | 8.01 On February 8, 2011, Flex Fuels Energy, Inc. (“the Company”), in furtherance of the Company’s ongoing dispute with its former external counsel, Mayer Brown International LLP (“Mayer Brown”), submitted a claim against Mayer Brown in the High Court of Justice, Chancery Division, London, England. | form8k.htm |
| 2010-07-29 | 8-K | 2010-07-23 | 1.01 Entry into a Material Definitive Agreement | 1.01 On July 23, 2010 we entered into a Subscription Agreement with our majority owned subsidiary, WDX Organisation Limited (“WDX”), and the founders of WDX under which we purchased 500,000 preference shares of WDX (the “Preference Shares”) at a price of one British Pound per share or an aggregate of 500,000 British Pounds (approximately US$750,000). | form8k.htm |
| 2010-03-11 | 8-K | 2010-03-08 | 2.01 Completion of Acquisition or Disposition of Assets | 2.01 On March 8, 2010 we entered into a second Call Option and Draw Down Agreement with WDX Organisation Limited (“WDX”) pursuant to which we loaned an additional £150,000 (approximately US$224,055) to WDX and executed certain call options. | form8k.htm |
| 2010-03-03 | 8-K | 2010-02-25 | 1.01 Entry into a Material Definitive Agreement | 1.01 On February 25, 2010 we entered into a Subscription and Shareholders Agreement with Bio AMD Holdings Limited (“Bio AMD”), a United Kingdom company, and the managers of Bio AMD, under which we acquired a 63% interest in Bio AMD for £865,000 British Pounds Sterling (approximately US$1,286,775) (the “Purchase Price”). | f8k030310.htm |
| 2009-12-01 | 8-K | 2009-11-20 | 2.01 Completion of Acquisition or Disposition of Assets | 2.01 On November 20, 2009 we loaned an additional £150,000 (approximately US$249,840) to WDX Organisation Limited (“WDX”) and increased our equity position in WDX from 68.33% to 75.66%. | form8k.htm |
| 2009-11-18 | 8-K | 2009-11-16 | 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review | 4.02 On November 16, 2009, in the course of completing our Quarterly Report on Form 10-Q for the quarter ended September 30, 2009, we determined that we are required to address the effects of an error in certain accounting treatment applied in the preparation of our September 30, 2008 financial statements filed by prior management. | form8k.htm |
| 2009-10-28 | 8-K | 2009-10-22 | 3.02 Unregistered Sales of Equity Securities | 3.02 Effective October 22, 2009 we issued an aggregate of 10,100,000 warrants to members of our management and a key employee, each exercisable, upon vesting, for the purchase of one share of our common stock for a period of seven years at an exercise price of $0.07 per share. | form8k.htm |
| 2009-10-13 | 8-K | 2009-10-09 | 1.01 Entry into a Material Definitive Agreement | 1.01 On October 9, 2009 we entered into a Stock Purchase Agreement (the “Stock Purchase Agreement”) with JTC Trustees Limited As Trustee of the LOGO Investment Trust (the “Shareholder”) whereby we purchased 7,865,341 shares of our common stock (the “Shares”) from the Shareholder at a price of $0.008 per share or an aggregate of approximately $62,923. | form8k.htm |
| 2009-07-06 | 8-K | 2009-07-03 | 7.01 Regulation FD Disclosure | 7.01 On July 3, 2009 we added a Power Point Presentation to our website, www.flexgp.com. | form8k.htm |
| 2009-06-11 | 8-K | 2009-06-05 | 8.01 Other Events | 8.01 Effective June 5, 2009, after having carefully evaluated all options, we determined to abandon our proposed oil seed business as we no longer consider the business to be economically viable on either a go alone or partnered basis. | form8k.htm |
| 2009-06-02 | 8-K | 2009-05-27 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Effective May 27, 2009 John Nangle resigned as our President and as a Director. | form8k.htm |
| 2009-05-27 | 8-K | 2009-05-21 | 1.01 Entry into a Material Definitive Agreement | 1.01 On May 21, 2009 we entered into Stock Purchase Agreements (the “Stock Purchase Agreements”) with Iestyn Morgan, Gillian Penton and Mark Paulson (collectively the “Shareholders”) whereby we agreed to purchase an aggregate of 16,989,136 shares of our common stock (the “Shares”) from the Shareholders at a price of $0.008 per share or an aggregate of approximately $135,913. | form8k.htm |
| 2009-05-07 | 8-K | 2009-05-01 | 1.01 Entry into a Material Definitive Agreement | 1.01 On May 1, 2009 we entered into an Investment Agreement (the “Investment Agreement”) with WDX Organisation Limited (“WDX”), a corporation incorporated under the laws of England and Wales, and the founding shareholders of WDX (the “Founders”), the owners of all of the issued and outstanding shares of WDX. | form8k.htm |
| 2009-01-20 | 8-K | 2009-01-13 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 (a) On January 13, 2009, Flex Fuels Energy, Inc. (the “Registrant” or the “Company”) notified BDO Stoy Hayward LLP (“BDO”) that it was dismissed as the Registrant’s independent registered public accounting firm. | form8k.htm |
| 2008-12-17 | 8-K | 2008-12-12 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | form8k.htm | |
| 2008-10-14 | 8-K | 2008-10-07 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | form8k.htm | |
| 2008-09-29 | 8-K | 2008-09-26 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | form8k.htm | |
| 2008-08-25 | 8-K | 2008-08-19 | 8.01 Other Events | form8k.htm | |
| 2008-08-15 | 8-K | 2008-08-14 | 8.01 Other Events | form8k.htm | |
| 2008-07-31 | 8-K | 2008-07-31 | 8.01 Other Events | form8k.htm | |
| 2008-07-17 | 8-K/A | 2008-07-17 | 8.01 Other Events | form8ka.htm | |
| 2008-07-16 | 8-K | 2008-07-16 | 8.01 Other Events | form8k.htm | |
| 2008-07-15 | 8-K | 2008-05-16 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | form8k.htm | |
| 2008-05-06 | 8-K | 2008-05-02 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | form8k.htm | |
| 2008-04-08 | 8-K | 2008-04-04 | 8.01 Other Events | form8k.htm | |
| 2008-03-06 | 8-K | 2008-03-03 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | form8k.htm | |
| 2007-10-18 | 8-K | 2007-10-16 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | form8k.htm | |
| 2007-10-09 | 8-K | 2007-09-28 | 1.01 Entry into a Material Definitive Agreement | form8k.htm | |
| 2007-09-14 | 8-K/A | 2007-05-29 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; 5.01 Changes in Control of Registrant | form8ka.htm | |
| 2007-08-14 | 8-K/A | 2007-05-29 | 9.01 Financial Statements and Exhibits | august142007.txt | |
| 2007-08-06 | 8-K | 2007-07-06 | 3.02 Unregistered Sales of Equity Securities; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | form8k.htm | |
| 2007-07-16 | 8-K | 2007-07-13 | 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review | form8k.htm | |
| 2007-07-03 | 8-K | 2007-06-29 | 4.01 Changes in Registrant's Certifying Accountant | form8k.htm | |
| 2007-06-12 | 8-K | 2007-06-11 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | form8k.htm | |
| 2007-06-05 | 8-K | 2007-05-29 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 3.02 Unregistered Sales of Equity Securities; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | form8k.htm | |
| 2007-05-02 | 8-K | 2007-04-26 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | form8k.htm | |
| 2007-01-05 | 8-K | 2006-12-29 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | form8k.htm | |
| 2006-12-26 | 8-K | 2006-12-18 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | form8k.htm |